TODD ROSENGART to Coronary Artery Bypass
This is a "connection" page, showing publications TODD ROSENGART has written about Coronary Artery Bypass.
Connection Strength
3.594
-
Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration. J Thorac Cardiovasc Surg. 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266.
Score: 0.302
-
Cognitive decline and ischemic microlesions after coronary catheterization: a comparison to coronary artery bypass. Am Heart J. 2012 Apr; 163(4):e13.
Score: 0.275
-
Absence of cognitive decline one year after coronary bypass surgery: comparison to nonsurgical and healthy controls. Ann Thorac Surg. 2008 May; 85(5):1571-8.
Score: 0.209
-
Invited commentary. Ann Thorac Surg. 2008 Jan; 85(1):64.
Score: 0.205
-
Stable cognition after coronary artery bypass grafting: comparisons with percutaneous intervention and normal controls. Ann Thorac Surg. 2006 Aug; 82(2):597-607.
Score: 0.185
-
Neurocognitive functioning in patients undergoing coronary artery bypass graft surgery or percutaneous coronary intervention: evidence of impairment before intervention compared with normal controls. Ann Thorac Surg. 2005 Oct; 80(4):1327-34; discussion 1334-5.
Score: 0.175
-
Low socioeconomic status adversely influences outcomes after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2025 11; 170(5):1480-1490.e5.
Score: 0.167
-
Safety of Early Discharge After Coronary Artery Bypass Grafting: A Nationwide Readmissions Analysis. Ann Thorac Surg. 2024 09; 118(3):701-710.
Score: 0.160
-
Machine Learning to Predict Outcomes and Cost by Phase of Care After Coronary Artery Bypass Grafting. Ann Thorac Surg. 2022 09; 114(3):711-719.
Score: 0.132
-
Single-Dose del Nido Cardioplegia Compared With Standard Cardioplegia During Coronary Artery Bypass Grafting at a Veterans Affairs Hospital. Tex Heart Inst J. 2021 01 01; 48(1).
Score: 0.126
-
Development of a Risk Score to Predict 90-Day Readmission After Coronary Artery Bypass Graft. Ann Thorac Surg. 2021 02; 111(2):488-494.
Score: 0.121
-
Incidence, Cost, and Risk Factors for Readmission After Coronary Artery Bypass Grafting. Ann Thorac Surg. 2019 06; 107(6):1782-1789.
Score: 0.109
-
Confusion Instead of Clarity: Publicly Reported Cardiac Surgery Ratings for Coronary Artery Bypass Grafting and Aortic Valve Replacement. J Am Coll Surg. 2019 02; 228(2):180-187.
Score: 0.108
-
Right for the Wrong Reasons: Implications of Data Insufficiency in Bilateral Versus Single Internal Thoracic Artery Grafting Analysis. J Am Heart Assoc. 2018 01 06; 7(1).
Score: 0.102
-
Use of cardiopulmonary pump support during coronary artery bypass grafting in the high-risk: a meta-analysis. Ir J Med Sci. 2018 May; 187(2):369-377.
Score: 0.100
-
Incidence, Predictors, and Impact of Postoperative Atrial Fibrillation after Coronary Artery Bypass Grafting in Military Veterans. Tex Heart Inst J. 2016 Oct; 43(5):397-403.
Score: 0.094
-
Trends in Robotic-Assisted Coronary Artery Bypass Grafts: A Study of The Society of Thoracic Surgeons Adult Cardiac Surgery Database, 2006 to 2012. Ann Thorac Surg. 2016 Jul; 102(1):140-6.
Score: 0.090
-
The Society of Thoracic Surgeons Clinical Practice Guidelines on Arterial Conduits for Coronary Artery Bypass Grafting. Ann Thorac Surg. 2016 Feb; 101(2):801-9.
Score: 0.089
-
Changes over time in risk profiles of patients who undergo coronary artery bypass graft surgery: the Veterans Affairs Surgical Quality Improvement Program (VASQIP). JAMA Surg. 2015 Apr; 150(4):308-15.
Score: 0.085
-
Heparin-induced thrombocytopenia and thrombosis: presentation after cardiopulmonary bypass. Ann Thorac Surg. 1994 Dec; 58(6):1764-6.
Score: 0.083
-
Trends in use of off-pump coronary artery bypass grafting: Results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. J Thorac Cardiovasc Surg. 2014 Sep; 148(3):856-3, 864.e1; discussion 863-4.
Score: 0.078
-
Reoperative coronary artery bypass surgery. Improved preservation of myocardial function with retrograde cardioplegia. Circulation. 1993 Nov; 88(5 Pt 2):II330-5.
Score: 0.077
-
Risk analysis of primary versus reoperative coronary artery bypass grafting. Ann Thorac Surg. 1993 Nov; 56(5 Suppl):S74-7.
Score: 0.077
-
Risk analysis for readmission after coronary artery bypass surgery: developing a strategy to reduce readmissions. J Am Coll Surg. 2013 Mar; 216(3):412-9.
Score: 0.072
-
Long-term follow-up assessment of a phase 1 trial of angiogenic gene therapy using direct intramyocardial administration of an adenoviral vector expressing the VEGF121 cDNA for the treatment of diffuse coronary artery disease. Hum Gene Ther. 2013 Feb; 24(2):203-8.
Score: 0.072
-
Development of a Machine Learning Model to Predict Outcomes and Cost After Cardiac Surgery. Ann Thorac Surg. 2023 06; 115(6):1533-1542.
Score: 0.035
-
Public reporting for coronary artery bypass graft surgery: The quest for the optimal scorecard. J Thorac Cardiovasc Surg. 2023 09; 166(3):805-815.e1.
Score: 0.034
-
Racial/ethnic differences persist in treatment choice and outcomes in isolated intervention for coronary artery disease. J Thorac Cardiovasc Surg. 2023 10; 166(4):1087-1096.e5.
Score: 0.034
-
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation. 1999 Aug 03; 100(5):468-74.
Score: 0.029
-
Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion. Ann Thorac Surg. 1998 Jan; 65(1):125-36.
Score: 0.026
-
Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation. 1997 Nov 04; 96(9 Suppl):II-194-9.
Score: 0.025
-
Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah's Witness patients: implications for a "bloodless" surgical technique. J Am Coll Surg. 1997 Jun; 184(6):618-29.
Score: 0.025
-
Cost containment in cardiac surgery: results with a critical pathway for coronary bypass surgery at the New York hospital-Cornell Medical Center. Best Pract Benchmarking Healthc. 1996 Jan-Feb; 1(1):21-8.
Score: 0.022
-
A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation. 1995 Oct 15; 92(8):2236-44.
Score: 0.022
-
Reoperations on the total aortic arch in 119 patients: short- and mid-term outcomes, focusing on composite adverse outcomes and survival analysis. J Thorac Cardiovasc Surg. 2014 Dec; 148(6):2967-72.
Score: 0.020
-
The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med. 2009 Feb; 122(2):152-61.
Score: 0.014
-
Recovery of neuromuscular function after cardiac surgery: pancuronium versus rocuronium. Anesth Analg. 2003 May; 96(5):1301-1307.
Score: 0.009
-
Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding. Ann Thorac Surg. 1996 Nov; 62(5):1431-41.
Score: 0.006